doi: 10.1007/BF02316877.
Reversal by tetrahydroaminoacridine of scopolamine-induced memory and performance deficits in rats
Affiliations
- PMID: 1745706
- DOI: 10.1007/BF02316877
Item in Clipboard
Reversal by tetrahydroaminoacridine of scopolamine-induced memory and performance deficits in rats
Psychopharmacology (Berl).
1991.
Abstract
The effects of the cholinesterase inhibitors physostigmine and tetrahydroaminoacridine (THA) on memory and performance deficits induced by scopolamine were studied using an operant delayed non-matching to position task. No effect was seen on the performance of rats when treated with either physostigmine (0.1 mg/kg IP) or THA (1 mg/kg IP) alone. However, the performance deficits induced in the task by scopolamine (0.03 mg/kg SC) were reversed by the same doses of the cholinesterase inhibitors.
Similar articles
-
Interactions between scopolamine and muscarinic cholinergic agonists or cholinesterase inhibitors on spatial alternation performance in rats.J Pharmacol Exp Ther. 1990 Dec;255(3):1071-7. J Pharmacol Exp Ther. 1990. PMID: 2262893
-
Direct comparison of cognitive facilitation by physostigmine and tetrahydroaminoacridine in two primate models.Neurobiol Aging. 1990 Nov-Dec;11(6):609-13. doi: 10.1016/0197-4580(90)90025-u. Neurobiol Aging. 1990. PMID: 2280804
-
Tacrine-scopolamine interactions on state-dependent retrieval.Psychopharmacology (Berl). 2003 Feb;166(1):33-9. doi: 10.1007/s00213-002-1292-y. Epub 2002 Dec 19. Psychopharmacology (Berl). 2003. PMID: 12491027
-
The behavioral effects of heptyl physostigmine, a new cholinesterase inhibitor, in tests of long-term and working memory in rodents.Pharmacol Biochem Behav. 1991 Aug;39(4):865-71. doi: 10.1016/0091-3057(91)90045-4. Pharmacol Biochem Behav. 1991. PMID: 1763105
-
Measurement of cholinergic drug effects on memory in Alzheimer's disease.Neurobiol Aging. 1983 Summer;4(2):139-45. doi: 10.1016/0197-4580(83)90038-6. Neurobiol Aging. 1983. PMID: 6355883 Review.
Cited by
-
Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-maze.Psychopharmacology (Berl). 1993;112(4):415-20. doi: 10.1007/BF02244888. Psychopharmacology (Berl). 1993. PMID: 7871051
-
Tacrine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in Alzheimer's disease.Drugs Aging. 1994 Jun;4(6):510-40. doi: 10.2165/00002512-199404060-00006. Drugs Aging. 1994. PMID: 7521234 Review.
-
A comparison of the effects of the novel muscarinic receptor agonists L-689,660 and AF102B in tests of reference and working memory.Psychopharmacology (Berl). 1994 Jan;113(3-4):361-8. doi: 10.1007/BF02245210. Psychopharmacology (Berl). 1994. PMID: 7862846
-
Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze.Psychopharmacology (Berl). 1993;111(4):435-41. doi: 10.1007/BF02253533. Psychopharmacology (Berl). 1993. PMID: 7870985
-
MKC-231, a choline uptake enhancer, ameliorates working memory deficits and decreased hippocampal acetylcholine induced by ethylcholine aziridinium ion in mice.J Neural Transm Gen Sect. 1994;98(1):1-13. doi: 10.1007/BF01277590. J Neural Transm Gen Sect. 1994. PMID: 7710736
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
